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IgE-mediated hypersensitivity refers to immune reactions that can be rapidly progressing and, in the case
of anaphylaxis, are occasionally fatal. To that end, identiﬁcation of the associated allergen is important for
facilitating both education and allergen avoidance that are essential to long-term risk reduction. As the
number of known exposures associated with anaphylaxis is limited, discovery of novel causative agents
is crucial to evaluation and management of patients with idiopathic anaphylaxis. Within the last 10 years
several apparently separate observations were recognized to be related, all of which resulted from the
development of antibodies to a carbohydrate moiety on proteins. Interestingly, the exposure differed
from airborne allergens but was nevertheless capable of producing anaphylactic and hypersensitivity
reactions. Our recent work has identiﬁed these responses as being due to a novel IgE antibody directed
against a mammalian oligosaccharide epitope, galactose-alpha-1,3-galactose (“alpha-gal”). This review
will present the historical summary of the identiﬁcation of cetuximab hypersensitivity due to alpha-gal
IgE and discuss the non-primate mammalian meat food allergy as well as current goals and directions of
our research programs.
Copyright © 2015, Japanese Society of Allergology. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
IgE antibodies to carbohydrate epitopes on allergens are
thought to be less common than IgE antibodies to protein epi-
topes and also of much less clinical signiﬁcance (see www.
allergen.org).1e3 Thus, when anaphylactic reactions to the
monoclonal antibody cetuximab were recognized as a major
regional complication of this cancer treatment the initial inves-
tigation focused on ﬁnding IgE antibodies to a protein epitope.4,5
It was unexpected when it became clear that these reactionsy, Allergy and Immunology,
na School of Medicine, 3300
80, USA.
mmins).
ety of Allergology.
rgology. Production and hosting by Elsewere causally related to pre-existing IgE antibodies (Ab) speciﬁc
for the glycosylation product galactose-alpha-1,3-galactose
(“alpha-gal”) moieties present on cetuximab.4 This carbohydrate
is a well-recognized immunologic barrier in xenotransplantation.
In fact, xenoreactive antibodies directed against the alpha-gal
moieties decorating non-primate mammalian tissue are often
implicated in acute organ rejection. For the ﬁeld of food allergy
and anaphylaxis, this discovery led to the ﬁnding that IgE Ab
to alpha-gal was implicated in the delayed food allergy to
mammalian meat (e.g., beef, pork, lamb). Not only have those
studies opened up investigations of how the IgE response to
alpha-gal is different from typical IgE responses directed towards
protein allergens but also raised global awareness and recogni-
tion of delayed reactions to red meat in numerous geographical
locales throughout the world.6e17vier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
Table 1
Details from summarized worldwide reports of alpha-gal allergy.
Country Suspected tick
species
Timing of
reactions
Implicated foods Reference
Australia Ixodes holocyclus 1e6 h N-PMM, kangaroo,
horse, gelatin
16,17
France 0.5e5 h N-PMM, pork
kidney, horse
8,9
Germany Ixodes ricinus 0.25e5 h N-PMM, pork
kidney, gelatin
12,13
Japan >2 h N-PMM 11
Panama Amblyomma
cajennense
1.5e6 h N-PMM 15
Spain Ixodes ricinus 2e6 h N-PMM 10
Sweden Ixodes ricinus 1.5e6 h N-PMM, moose 14,26
United
States
Amblyomma
americanum
2e6 h N-PMM, squirrel,
gelatin
6,7,22,24
N-PMM, non-primate mammalian meat ¼ e.g., beef, pork, lamb, goat, venison,
rabbit.
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In clinical trials for the monoclonal antibody (mAb) cetuximab,
which is speciﬁc for the epidermal growth factor receptor (EGFR), it
became clear that the antibody was causing hypersensitivity re-
actions in a group of southern US states that were not evident
elsewhere.5 Importantly, there were two anaphylactic reactions to
cetuximab in Bentonville, Arkansas in 2006. These reactions to
cetuximab developed rapidly during the ﬁrst infusion of the anti-
body and occasionally proved fatal, including one in Benton-
ville.4,5,18 In part because our group had developed the IgE
ﬂuorometric enzyme immunoassay or CAP assay to cetuximab
using the streptavidin technique, we were subsequently asked to
investigate the reactions to cetuximab.19 Through a series of col-
laborations, we demonstrated that the patients who had reactions
to cetuximab also had IgE antibodies speciﬁc for this molecule
before they started treatment.4 Characterization of cetuximab
glycosylation revealed 21 distinct oligosaccharide structures, of
which approximately 30% have one or more alpha-1,3 linked
galactosyl residues.20 Analysis of the IgE antibodies to cetuximab
demonstrated that these antibodies were, in fact, speciﬁc for the
galactose-alpha-1,3-galactose (alpha-gal) residues on the heavy
chain portion of the mAb.20 In keeping with what is known about
IgE Ab and responses, a desensitization protocol for cetuximab has
been established and continues to be successfully used for patients
requiring the medication despite the presence of IgE to alpha-gal.21
The red meat connection
Also in the 2006e2008 time period, we evaluated a number of
patients who had presented with episodes of generalized urticaria,
angioedema or recurrent anaphylaxis. Despite there being no clear
immediate cause for their symptoms, several of the patients re-
ported that they felt the reactions might be due to eating meat
3e5 h earlier. Prick tests were performed with commercial extracts
of beef, pork or lamb and produced small wheals that often would
be reported as negative. However, given the compelling history
described by the patients, we extended our analysis to intradermal
skin testing with commercial meat extracts or prick skin tests with
fresh meat extracts both of which demonstrated strong positive
results.7 The skin ﬁndings were conﬁrmed with blood tests for
speciﬁc IgE Ab to alpha-gal and mammalian antigens.7
It is important to note that we were not alone in ﬁnding a
connection between eating red meat and allergic reactions in
adults. In fact, anaphylactic or urticarial reactions to red meat were
recognized in Australia due to the original observations of Dr.
Sheryl Van Nunen.17 In 2006, she had reported to the New South
Wales Allergy Society that individuals who had experienced tick
bites were at risk of reactions following ingestion of red meat
perhaps due to an antigen transmitted from ticks feeding on the
small mammal bandicoot. Her results were published in 2009 and
related to the published evidence about IgE to alpha-gal.4,7,17 Sub-
sequently, with Dr. Mullins we conﬁrmed that the patients with
delayed reactions to red meat in Australia had IgE antibodies spe-
ciﬁc for alpha-gal.16 Cases of reactions to red meat have now been
extended to include children22 and identiﬁed in France, Sweden,
Germany, Japan, and Australia as well as in the United States
(Table 1, Fig. 1).6e17
In our most recent survey, we have seen over 1500 cases of
delayed urticaria or anaphylaxis to red meat in Virginia and North
Carolina. We have evaluated a subset of these patients for symp-
toms, lung function, exhaled NO, and serum IgE. The resulting ev-
idence demonstrated that IgE to alpha-gal had no association with
asthma.23 Thus even patients with high titer IgE to alpha-gal living
in a house with a cat had no increase in their risk of asthma. Thiswas surprising since cats, like all non-primate mammals, have
alpha-gal on many of their proteins and lipids. On the other hand,
using an assay for alpha-gal, wewere not able to detect this antigen
airborne in homes with a cat evenwhere Fel d 1was present at high
levels.23
The characteristics of reactions due to alpha-gal IgE are different
from typical food allergic reactions. While common complaints
include both gastrointestinal symptoms and hives, patients do not
develop any symptoms until several hours after eating red meat. In
fact, many reactions are delayed for 4e6 h or even longer. Although
the most common reported and observed symptom that heralded a
reaction was pruritus, symptoms can progress to be severe or even
life threatening. Many patients do not report any symptoms prior to
the onset of a reaction and, equally, symptoms do not occur with
every exposure to red meat. In each known instance, the onset of
allergic reactions due to alpha-gal represented a break in oral
tolerance where the patient had tolerated mammalian meat in the
past, often for over 25 years.
More recently we have begun to recognize clinical nuances re-
ported by patients with the alpha-gal food allergy. It appears as
though some patients have a relatively straightforward clinical
course once the diagnosis of IgE to alpha-gal is made. In these
patients, clinical guidance related to an appropriate avoidance diet
of eliminating beef, pork, lamb (and other sources of non-primate
mammalian meat) is sufﬁcient to effectively cease the allergic re-
actions. It bears noting that such patients largely reported reactions
conﬁned to episodes of consuming fatty portions of red meat. On
the contrary, an apparent subset of patients diagnosed with IgE to
alpha-gal develops a more sensitive response to alpha-gal con-
taining foods and products. In these instances, we have noted that
elimination of mammalian meat alone does not result in complete
amelioration of reactions. Our clinical approach has been to follow
meat avoidance with dietary elimination of dairy and related foods.
If this step does not lead to cessation of reactions, complete
avoidance of alpha-gal containing productse to include gelatin and
other by-products, may be necessary. Reconciling the various,
nuanced clinical presentations of this unique food allergy with a
scientiﬁc understanding of the explanation are the subject of
ongoing studies. One potential hint might be found in the ongoing
mass cytometry studies which allow for a detailed analysis of B cell
populations. We are testing the hypothesis that the levels at which
patients show loss of tolerance to select foods vs. all alpha-gal
products are reﬂected in the emergence of B cell subsets that
correlate with auto-immunity signatures, such as seen in lupus or
arthritis. Alternatively, the number, amount and chronicity of tick
bites could be important in creating an IgE Ab response that has
Fig. 1. Outline map of the world showing relative location of geographical distribution of reported cases of patients with delayed allergic reactions to non-primate mammalian meat
due to IgE to alpha-gal.
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tially have binding characteristics for the alpha-gal epitope that
result in a more profound loss of clinical tolerance to non-primate
mammalian foods and products.Ticks and delayed anaphylaxis
Currently, it is our hypothesis that bites from ecto-parasitic
ticks are the sensitizing event that leads to the development of
sIgE to the oligosaccharide alpha-gal, which results in a loss of
tolerance to non-primate mammalian meat and related food
products in some individuals.24 The evidence for tick bites as a
major cause of IgE to alpha-gal comes from several observations
(Box 1). First we have documented increases in IgE antibodies afterBox 1
Evidence supporting a role for tick bites in the development of
sIgE response to alpha-gal.
 Four cases reported in detail where there is epidemiologic
evidence that sIgE to alpha-gal increased following
documented tick bites
 The IgE antibodies to alpha-gal are found in areas where
tick bites are common
 IgE antibodies to alpha-gal correlate with the presence of
IgE antibodies to tick proteins
 The known global distribution of delayed anaphylactic
reactions to red meat is similar to the known distribution
of various tick species
 Staining of the gastrointestinal tract of Ixodes ricinus
showed the presence of galactose-alpha-1,3-galactose
(see Ref. 26)tick bites in four subjects. Second, there is a signiﬁcant correlation
between reports of prolonged itching after tick bites and the
presence of IgE antibodies to alpha-gal in the serum. Bites of larval
lone star ticks, like adult ticks, can be intensely pruritic. Interest-
ingly, bites from the deer tick Ixodes scapularis, which transmits
Lyme disease, do not generally induce a pruritic skin response. In
fact, itching after tick bites has been associated with a decrease in
the risk of developing positive Lyme serology.25 Third, there is an
excellent correlation between IgE to alpha-gal and IgE to extract of
the lone star tick (r ¼ 0.75; p < 0.001).24 In addition, recent evi-
dence from Professor van Hage's group in Stockholm demon-
strating the presence of alpha-gal in the gut of the tick and a
similar correlation with tick bites in southern Sweden has
strengthened this correlation.26 Finally, subjects living in areas
void of ticks do not have IgE to alpha-gal.4,14,23 The lone star tick is
the primary tick in the USA whose larvae bite humans, and in
several cases we have found high titer IgE antibodies to alpha-gal
following bites from larval ticks, often known as “seed ticks”. One
of our current research questions is to understand why tick bites
can give rise to such a dramatic IgE response andwhy those IgE Abs
are speciﬁcally directed against the alpha-gal oligosaccharide. In
the process, we will investigate whether this response has more in
common with other responses to oligosaccharides (e.g., of the IgM
class) or with IgE responses to proteins (e.g., undergone sequential
class-switching). There is increasing evidence that the skin can be
an important route for IgE Ab responses to proteins such as peanut
and wheat.27,28 However, with those antigens neither the process
through which the antigen enters the skin nor the time frame from
exposure to antibody response is known. We do not believe that
every person bitten by a tick ends up with an IgE response and
another of our goals is to determine whether there are inherent
factors that create a risk for the IgE response. In many ways, the
alpha-gal IgE response is similar to the sensitization that occurs to
inhaled plant oligosaccharides such as MUXF3 e a hapten on the
glycoproteins of many plant species.1,29,30 Unlike alpha-gal, IgE
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terminants (CCDs) have not been shown to contribute to symp-
toms related to pollen exposure.1e3,31
Patients with IgE to alpha-gal typically report symptoms
beginning 3e6 h after eating meat.7 In formal challenge studies
using pork or beef, hives and other symptoms were delayed at least
two hours after meat ingestion.32 More recent work has shown that
the time frame to reaction can be decreased with co-factors such as
exercise or alcohol.12 Delayed reactions after eating meat are
distinct from the reactions to cetuximab, which develop rapidly
and symptoms often peak within 20 min of initial administration of
the drug.4,5,18 In keeping with the more rapid time frame, in vitro
responses of basophils isolated from subjects with delayed meat
reactions show activation with glycoproteins within 20e30 min.32
Skin test responses, whether prick or intradermal, to cetuximab
are also rapid.8 Thus, the delay in response after eating meat does
not reﬂect an inability of basophils or mast cells to be activated by
these glycoproteins. On the contrary, we believe that the results to
date suggest the allergenic form of the oligosaccharide enters the
circulation several hours after eating. Lipids would make a likely
form of the allergen given the absorption and processing that must
occur before these particles enter the bloodstream.33 In fact, alpha-
gal is present on both glycoproteins and glycolipids (including
chylomicrons).34 Our current concept is that the most likely
explanation for the delay in symptoms is that the allergenic form of
alpha-gal exists as a glycolipid.
Our studies have shown that during a challenge, circulating
basophils assessed ex vivo upregulate the expression of CD63 in a
similar time frame as the patients develop symptoms.32 Surpris-
ingly, a proportion of non-allergic controls also demonstrated
upregulation of CD63, although they do not experience any
symptoms. Evidence that basophils and mast cells have receptors
for LDL was reported many years ago.35,36 One potential explana-
tion for this enigmatic ﬁnding is that the existing IgG or IgM
response speciﬁc for alpha-gal (known as “anti-Gal”37) present in
all immunocompetent individuals is binding alpha-gal glycolipids
and activating basophils to upregulate CD63. The implication is that
lipid particles with alpha-gal on the surface can cause pro-
inﬂammatory mediator release not only in individuals with IgE
Ab to alpha-gal but also in those who are non-allergic. The long-
term, potential ramiﬁcation of pro-inﬂammatory mediator release
due to eating mammalian meat could begin to look like a society
with high rates of atherosclerotic cardiovascular disease that may
not be amenable to existing pharmacologic therapy because it is
driven by antibody-mediated lipid uptake. These possibilities are
areas of ongoing and future investigations for our group.
Conclusion
The ﬁnding that IgE to alpha-gal explains two novel forms of
anaphylaxis has not only changed several established rules about
allergic disease, but has opened up at least two new areas of
research. The results provide evidence that: IgE responses to an
oligosaccharide can induce signiﬁcant or severe allergic symptoms,
ticks can induce high titer food speciﬁc IgE responses in adult life
breaking long-held periods of oral tolerance, and also that eating
mammalian products carrying this epitope does not give rise to any
symptoms during the few hours or more. Like so many new ﬁnd-
ings, this area of research provides both challenges and opportu-
nities. The delay in onset of symptoms following eating red meat is
best explained by delayed arrival of the relevant form of antigen in
the circulation, but the question remains as to what form of
glycoprotein or more likely glycolipid takes 3 h ormore to appear in
the circulation. Finally, the often-rapid production of IgE antibodies
to alpha-gal after tick bites provides a striking model of an ecto-parasite-induced IgE response. This parasite only enters through
the skin and the tick saliva contains a wide variety of agents that
could act as antigens and/or as adjuvants. However, it remains a
striking challenge to identify why the response is so robust and
why it is directed so consistently against the alpha-gal carbohy-
drate residue.
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